Levaquin Claims Should Not Include Intermediate Resistant Strains - Cmte.
Executive Summary
A penicillin-resistant community-acquired pneumonia indication for Johnson & Johnson's Levaquin should not mention intermediate resistant strains so as not to encourage overuse, FDA's Anti-Infective Drugs Advisory Committee determined Oct. 20.